Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.120
-0.180 (-5.45%)
At close: Oct 30, 2026, 4:00 PM EDT
3.130
+0.010 (0.32%)
After-hours: Oct 30, 2026, 7:50 PM EDT
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $108.46 million as of October 30, 2026. It is the 24,456th most valuable company in the world and the 4,026th biggest in the United States. Its market cap has decreased by 20.77% in one year.
Market Cap
108.46M
Enterprise Value
94.77M
1-Year Change
-20.77%
Global Rank
Country Rank
#4,026 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $108.46M, an increase of 30.36%. That is a compound annual growth rate of 0.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 108.50M | 5.65% |
| Dec 31, 2025 | 102.70M | 37.48% |
| Dec 31, 2024 | 74.70M | -38.06% |
| Dec 29, 2023 | 120.60M | -7.44% |
| Dec 30, 2022 | 130.30M | 46.40% |
| Dec 31, 2021 | 89.00M | 21.92% |
| Dec 31, 2020 | 73.00M | 10.11% |
| Dec 31, 2019 | 66.30M | -10.04% |
| Dec 31, 2018 | 73.70M | 106.44% |
| Dec 29, 2017 | 35.70M | -24.52% |
| Dec 30, 2016 | 47.30M | 79.85% |
| Dec 31, 2015 | 26.30M | 10.04% |
| Dec 31, 2014 | 23.90M | -39.34% |
| Dec 31, 2013 | 39.40M | 18.32% |
| Dec 31, 2012 | 33.30M | 73.44% |
| Dec 30, 2011 | 19.20M | -39.81% |
| Dec 31, 2010 | 31.90M | -65.14% |
| Dec 31, 2009 | 91.50M | 61.95% |
| Dec 31, 2008 | 56.50M | -63.00% |
| Dec 31, 2007 | 152.70M | 62.27% |
| Dec 29, 2006 | 94.10M | 31.24% |
| Dec 30, 2005 | 71.70M | -0.42% |
| Dec 31, 2004 | 72.00M | 94.07% |
| Dec 31, 2003 | 37.10M | 183.21% |
| Dec 31, 2002 | 13.10M | -52.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 114.23M |
| Outlook Therapeutics | 113.96M |
| Nkarta | 111.73M |
| Minerva Neurosciences | 110.77M |
| Anavex Life Sciences | 110.31M |
| PolyPid | 109.48M |
| Equillium | 107.36M |
| OnKure Therapeutics | 106.10M |